99% Savings - Buy Just @1 Rs X
Glycopyrolate And Neostigmin is a prescription drug, available for use as Injection. Peptic Ulcer, Myasthenia Gravis are some of its major therapeutic uses. Glycopyrolate And Neostigmin also has some secondary and off-label uses. These are listed below.
The right dosage of Glycopyrolate And Neostigmin depends on the age, gender, and medical history of the patient. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Glycopyrolate And Neostigmin side effects, there are can be others also. These have been listed below. Normally, these side effects of Glycopyrolate And Neostigmin are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Glycopyrolate And Neostigmin is Unknown for pregnant women and Mild for women who are breastfeeding. It is important to know if Glycopyrolate And Neostigmin has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Glycopyrolate And Neostigmin related warnings section.
Glycopyrolate And Neostigmin is contraindicated in people with pre-existing medical conditions like Glaucoma, Arrhythmia, Tardive Dyskinesia as it can result in adverse effects. Other conditions have been mentioned below in the Glycopyrolate And Neostigmin contraindications section.
Besides this, Glycopyrolate And Neostigmin may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Glycopyrolate And Neostigmin is considered not safe while driving, and is not addictive.
Glycopyrolate And Neostigmin is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Glycopyrolate And Neostigmin safe for pregnant women?
The effects of Glycopyrolate And Neostigmin on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Glycopyrolate And Neostigmin safe during breastfeeding?
Glycopyrolate And Neostigmin has been seen to have minimal side effects on breastfeeding women.
What is the effect of Glycopyrolate And Neostigmin on the Kidneys?
Glycopyrolate And Neostigmin may have mild side effects on the kidneys.
What is the effect of Glycopyrolate And Neostigmin on the Liver?
Glycopyrolate And Neostigmin does not damage the liver.
What is the effect of Glycopyrolate And Neostigmin on the Heart?
Glycopyrolate And Neostigmin is rarely harmful for the heart.
Glycopyrolate And Neostigmin should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Glycopyrolate And Neostigmin unless your doctor advises you to do so -
Is this Glycopyrolate And Neostigmin habit forming or addictive?
No, there is no any evidence that Glycopyrolate And Neostigmin is addictive.
Interaction between Food and Glycopyrolate And Neostigmin
Taking Glycopyrolate And Neostigmin with food does not cause any problems.
Interaction between Alcohol and Glycopyrolate And Neostigmin
Drinking alcohol while taking Glycopyrolate And Neostigmin may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Robinul Injection (Glycopyrrolate Injection)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 117
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 619-620
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Bloxiverz™ (Neostigmine Methylsulfate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 107